Skip to Main Content
Table 1—

Demographic variables for the three study groups

Study 1Study 2Study 3
Age (years) 37.5 ± 0.9 (23–59) 50 ± 11 (28–75) 39.4 ± 10.4 (25–61) 
Disease duration (years) 19.7 ± 9.9 (2–46) 10 ± 9 (1–35) 20.2 ± 10.7 (1–52) 
Mean blood glucose (mmol/l) 9.6 ± 1.8 (4.7–16.9) 9.7 ± 3.7 (5.9–23.9) 9.3 ± 5.1 (1.1–33.3) 
HbA1c (%) 8.6 ± 2.3 (6.3–16.9)* 6.9 ± 1 (7–14) 7.6 ± 1.2 (4.0–12.6) 
BMI (kg/m2NA 34 ± 10 (19–65) 25.4 ± 4.4 (17.7–41.2) 
% female 62 42 57 
% using insulin 100 58 100 
Study 1Study 2Study 3
Age (years) 37.5 ± 0.9 (23–59) 50 ± 11 (28–75) 39.4 ± 10.4 (25–61) 
Disease duration (years) 19.7 ± 9.9 (2–46) 10 ± 9 (1–35) 20.2 ± 10.7 (1–52) 
Mean blood glucose (mmol/l) 9.6 ± 1.8 (4.7–16.9) 9.7 ± 3.7 (5.9–23.9) 9.3 ± 5.1 (1.1–33.3) 
HbA1c (%) 8.6 ± 2.3 (6.3–16.9)* 6.9 ± 1 (7–14) 7.6 ± 1.2 (4.0–12.6) 
BMI (kg/m2NA 34 ± 10 (19–65) 25.4 ± 4.4 (17.7–41.2) 
% female 62 42 57 
% using insulin 100 58 100 

Data are means ± SD (range) unless otherwise noted.

*

HbA1c estimate based on HbA1 assay.

Close Modal

or Create an Account

Close Modal
Close Modal